Key result
IV amiodarone followed by hemodialysis-induced hypokalemia triggers excessive QT prolongation and TdP in a case.
Case Report (n=1)
Intravenous amiodarone can induce torsades de pointes in patients with tachycardia-induced cardiomyopathy, especially when complicated by hemodialysis-induced hypokalemia.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to monitor QT with IV amiodarone plus hypokalemia; hypothesis-generating for TdP risk in cardiomyopathy.
We report a 77-year-old human on renal dialysis for end-stage renal disease with heart failure and atrial fibrillation (AF) complicated by a high ventricular frequency. The underlying disease was thought as tachycardia-induced-cardiomyopathy. Intravenous infusion of amiodarone was initiated, and direct current cardioversion succeeded in converting AF to sinus rhythm. Then, excessive increases in the QT and Tpeak-Tend (Tp-e) intervals were seen and hypokalemia induced by hemodialysis led to the development of numerous episodes of torsades de pointes (TdP). Magnesium repletion was effective in preventing TdP, while Tp-e intervals returned to the previous values 2 days after the discontinuation of amiodarone.
No takes yet. Share an insight, caveat, or question.
Yonai et al. (2020) conducted a case report in Tachycardia-induced-cardiomyopathy, atrial fibrillation, end-stage renal disease (n=1). Intravenous amiodarone was evaluated on Torsades de pointes (TdP). Intravenous amiodarone therapy followed by hemodialysis-induced hypokalemia led to excessive QT and Tp-e interval prolongation and numerous episodes of torsades de pointes in a 77-year-old patient.
Synapse has enriched 10 related papers. Consider them for comparative context: